ArticleCancer2013

Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.

Karen A Autio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.